Sherbrooke-based cleantech startup BioAlert Solutions has raised $2.5 million in seed funding to scale its automated water quality monitoring system, which helps detect and manage harmful pathogens such as Legionella in building water systems.
Sherbrooke-based cleantech startup BioAlert Solutions has raised $2.5 million in seed funding to scale its automated water quality monitoring system, which helps detect and manage harmful pathogens such as Legionella in building water systems.
Alkmaar-based DOPS Recycling Technologies has raised €5 million in seed funding to accelerate the development and scaling of its innovative Direct Carbon Immobilisation (DCI) technology, which converts waste and biomass into valuable raw materials while significantly cutting CO₂ emissions.
Munich-based Marvel Fusion has raised an additional €50 million in an extension of its Series B round, bringing the total raised in that round to €113 million and its overall funding to €385 million.
Antwerp-based ClimateCamp has secured €3.5 million in seed funding to scale its platform that helps companies measure, report, and reduce Scope 3 emissions—the indirect emissions tied to supply chains and product lifecycles.
Mercury, a digital banking platform for startups and small businesses, has closed a $300 million Series C round, pushing its valuation to $3.5 billion—more than double its 2021 valuation of $1.62 billion.
San Francisco-based edtech startup Brisk has raised $15 million in Series A funding to expand its AI-powered platform for teachers and students, positioning itself as a leader in building an AI-native education tech stack.
Marseille-based GravitHy, a sustainable iron technology startup, has raised €60 million in funding to drive forward its mission of decarbonizing the steel industry.
Waterloo-based logistics software firm Descartes Systems Group has acquired Ohio-based 3Gtms (3G) for $164.4 million CAD ($115M USD) in an all-cash deal, strengthening its domestic transportation management capabilities in North America.
Berlin-based AMBOSS, a leading platform for medical education and clinical decision-making, has raised €240 million in fresh funding to accelerate its global expansion and broaden its offerings to include nurses and additional healthcare professionals.
